Clinical TrialsSearch results
Number of results: 237
Completed
- Navigation surgery using ICG
- Colorectal cancer
- Kenji Baba
- 2019-03-28
Completed
- A Phase 3, Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
- Hyperphosphatemia Patients on Hemodialysis
- Kinoshita Jun
- 2021-03-04
Other
- Safety and efficacy of Alternating mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab every 4cycles as First line Therapy in Advanced colorectal Cancer
- Unresectable advanced/recurrent colorectal cancer
- KSCC
- 2008-08-12
Other
- Safety and efficacy of Alternating mFOLFOX6 and FOLFIRI every 4cycles as First line Therapy in Advanced colorectal Cancer
- Unresectable advanced/recurrent colorectal cancer
- KSCC
- 2008-08-29
Other
- Phase II study of combination therapy with Irinotecan and S-1 in patients with progressive colorectal cancer after FOLFOX regimen
- Unresectable advanced/recurrent colorectal cancer
- KSCC
- 2008-08-29
Other
- Feasibility study of Capecitabine as adjuvant chemotherapy for stage III colon cancer including RS cancer.
- stage III colon cancer including RS cancer
- KSCC
- 2008-10-22
Other
- Assessment of clinical usefulness in CKD patients with atorvastatin trial (ASUCA Trial)
- Hyperlipidemia with Chronic Kidney Disease (CKD)
- Kyoto University Graduate School of Medicine
- 2009-03-17
Other
- Phase II study of sequential administration of FEC (Fluorouracil / Epirubicin / Cyclophosphamide) followed by Docetaxel as adjuvant chemotherapy for node-positive breast cancer
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2006-04-06
Other
- Neo-adjuvant therapy with paclitaxel followed by FEC fluoraouracil, epirubicin and cyclophosphamide) for primary breast cancer(KBC-SG0801)
- Primary breast cancer
- Kyushu Breast Cancer Study Group
- 2009-02-27
Other
- Feasibility study of TC(docetaxel+Cyclophosphamide)as adjuvant chemotherapy for intermediate risk primary breast cancer with HER2-negative and ER-positive tumor(KBC-SG 0803)
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17